Results 111 to 120 of about 4,091 (198)

Triglyceride-lowering therapies for hepatic steatosis: mechanisms, efficacy, and clinical perspectives. [PDF]

Front Pharmacol
Tamehri Zadeh SS, Toth PP, Banach M.
europepmc   +1 more source

The Molecular Mechanisms of Metformin's Action on Blood Lipid Profile in Diabetic Patients. [PDF]

Int J Mol Sci
Dettlaff-Pokora A, Swierczynski J.
europepmc   +1 more source

ANGPTL3, Apo CIII, Leptin and Triglycerides Are Elevated in Metastatic Prostate Cancer. [PDF]

Cancers (Basel)
Boulay G, Khodr M, Bergeron AC, Wong Chong É, Joncas FH, Castonguay C, Robitaille K, Hovington H, Fradet V, Bergeron A, Pouliot F, Blais J, Seidah NG, Calon F, Gangloff A.   +14 more
europepmc   +1 more source

Correction: The ANGPTL3-integrin α5 axis drives retinal vascular leakage in diabetic retinopathy. [PDF]

J Transl Med
Ke J, Xu Y, Zhu Y, Feng X, Cao H, Yang L, Zhao D.   +6 more
europepmc   +1 more source

ANGPTL3 in the Peripheral Circulation Is Associated with Resistance to Anti-PD1 Therapy in Advanced Gastric Cancer. [PDF]

Cancer Res Commun
Kudo-Saito C, Shoji H, Nagashima K, Imazeki H, Tsugaru K, Takahashi N, Kawakami T, Amanuma Y, Wakatsuki T, Okano N, Narita Y, Yamamoto Y, Kizawa R, Muro K, Boku N.   +14 more
europepmc   +1 more source

ANGPTL3 and residual atherosclerotic risk: from lipid metabolism to therapeutic targeting. [PDF]

Front Endocrinol (Lausanne)
Weng S, Ding C, Lin J, Chai D.
europepmc   +1 more source

Current and Emerging Pharmacological Therapies for Hypertriglyceridemia. [PDF]

Int J Mol Sci
Alhomoud IS.
europepmc   +1 more source

Efficacy and safety of small interfering RNA (siRNA) therapies for hypertriglyceridemia and mixed dyslipidemia: an updated systematic review and meta-analysis. [PDF]

Front Pharmacol
Gao Y, Bai Y, Mu X, Pang X.
europepmc   +1 more source

ANGPTL3 in Podocytes Contributes to the Pathogenesis of Lupus Nephritis by Activating MSR1 in Macrophages. [PDF]

Kidney Dis (Basel)
Lv Q, Zhao N, Fang M, Xu L, Zhou X, Sun Y, Qi Q, Luo M, Xu H, Rao J.   +9 more
europepmc   +1 more source

Angiopoietin-like Protein 3 (ANGPTL3) Targeting in the Management of Dyslipidemias. [PDF]

Int J Mol Sci
Kosmas CE, Rallidis LS, Hoursalas I, Papakonstantinou EJ, Kostara CE.   +4 more
europepmc   +1 more source